Spots Global Cancer Trial Database for adenocarcinoma of the lung
Every month we try and update this database with for adenocarcinoma of the lung cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Icotinib for Completed Resected IB NSCLC With EGFR Mutation | NCT02264210 | Lung Neoplasms Squamous Cell L... Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Bronchial Neopl... Stage IB Non-sm... | Icotinib | 18 Years - 75 Years | Sun Yat-sen University | |
| Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00002623 | Lung Cancer | carboplatin cisplatin conventional su... radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00661193 | Lung Cancer | carboplatin erlotinib hydro... paclitaxel | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery | NCT00551369 | Lung Cancer | SBRT | 18 Years - | Radiation Therapy Oncology Group | |
| Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00553462 | Lung Cancer | carboplatin erlotinib hydro... paclitaxel albu... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction | NCT00009789 | Lung Cancer | accelerated con... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer | NCT00897533 | Lung Cancer | gene mapping polymorphism an... diagnostic labo... immunohistochem... | - 120 Years | Eastern Cooperative Oncology Group | |
| S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00085501 | Lung Cancer | cetuximab carboplatin paclitaxel | 18 Years - | SWOG Cancer Research Network | |
| Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy | NCT01208064 | Lung Cancer | pazopanib hydro... laboratory biom... pharmacogenomic... pharmacological... quality-of-life... | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC | NCT02059967 | Adenocarcinoma ... Large Cell Lung... Squamous Cell L... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... | Paclitaxel image-guided ad... carboplatin | 18 Years - | Virginia Commonwealth University | |
| Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer | NCT00897533 | Lung Cancer | gene mapping polymorphism an... diagnostic labo... immunohistochem... | - 120 Years | Eastern Cooperative Oncology Group | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer | NCT00006458 | Lung Cancer | indium In 111 m... yttrium Y 90 mo... | 18 Years - | National Cancer Institute (NCI) | |
| Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00425646 | Lung Cancer | bevacizumab imatinib mesyla... | 18 Years - | University of Washington | |
| Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer | NCT00087438 | Lung Cancer | stereotactic bo... | 18 Years - | Radiation Therapy Oncology Group | |
| Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC | NCT02059967 | Adenocarcinoma ... Large Cell Lung... Squamous Cell L... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... | Paclitaxel image-guided ad... carboplatin | 18 Years - | Virginia Commonwealth University | |
| Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT00023673 | Lung Cancer | carboplatin paclitaxel three-dimension... | - | Radiation Therapy Oncology Group | |
| Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | NCT00003202 | Lung Cancer | cisplatin gemcitabine hyd... radiation thera... | - 120 Years | Wake Forest University Health Sciences | |
| Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00005838 | Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | shark cartilage... placebo cisplatin vinorelbine tar... carboplatin paclitaxel radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | NCT00033410 | Lung Cancer | carboplatin paclitaxel tirapazamine radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT01345851 | Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Recurrent Non-s... Squamous Cell L... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... | hypofractionate... laboratory biom... image-guided ra... carboplatin paclitaxel stereotactic bo... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT00117962 | Lung Cancer | cetuximab carboplatin pemetrexed diso... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer | NCT00118144 | Adenocarcinoma ... Bronchoalveolar... Non-small Cell ... Recurrent Non-s... Stage IIIB Non-... Stage IV Non-sm... | bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00293280 | Lung Cancer | lomustine | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00002623 | Lung Cancer | carboplatin cisplatin conventional su... radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer | NCT00026156 | Lung Cancer | docetaxel vinorelbine tar... | 18 Years - | SWOG Cancer Research Network | |
| Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLC | NCT00354549 | Lung Cancer | bevacizumab + e... gemcitabine hyd... | 18 Years - 120 Years | Swiss Group for Clinical Cancer Research | |
| Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy | NCT00093132 | Carcinoma, Non-... Lung Cancer | Satraplatin | 18 Years - | Agennix | |
| SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00002642 | Lung Cancer | cisplatin etoposide conventional su... low-LET cobalt-... | 18 Years - | SWOG Cancer Research Network | |
| Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer | NCT00955695 | Lung Cancer | erlotinib hydro... gefitinib questionnaire a... quality-of-life... whole-brain rad... | 18 Years - | National Cancer Institute (NCI) | |
| Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer | NCT00728845 | Lung Cancer | bevacizumab carboplatin hydroxychloroqu... paclitaxel | 18 Years - 120 Years | Rutgers, The State University of New Jersey | |
| Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer | NCT00005630 | Lung Cancer | ras peptide can... sargramostim | 17 Years - | Memorial Sloan Kettering Cancer Center | |
| S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer | NCT00090961 | Lung Cancer Pulmonary Compl... | educational int... supervised exer... | - | SWOG Cancer Research Network | |
| Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer | NCT01259089 | Adenocarcinoma ... Non-small Cell ... | erlotinib hydro... Hsp90 inhibitor... laboratory biom... needle biopsy mutation analys... pharmacological... | 18 Years - | Northwestern University | |
| Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status | NCT00986297 | Lung Cancer | hypofractionate... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00798603 | Lung Cancer | bevacizumab carboplatin pemetrexed diso... | 70 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00217698 | Lung Cancer | cisplatin gefitinib gemcitabine hyd... | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00293280 | Lung Cancer | lomustine | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer | NCT00369551 | Adenocarcinoma ... Bronchoalveolar... Large Cell Lung... Stage II Non-sm... Stage IIIA Non-... Stage IIIB Non-... | 3-dimensional c... paclitaxel bevacizumab carboplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT00023673 | Lung Cancer | carboplatin paclitaxel three-dimension... | - | Radiation Therapy Oncology Group | |
| Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00425646 | Lung Cancer | bevacizumab imatinib mesyla... | 18 Years - | University of Washington | |
| Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00217698 | Lung Cancer | cisplatin gefitinib gemcitabine hyd... | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer | NCT00002852 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Squamous Cell L... Stage IB Non-sm... | paclitaxel carboplatin therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer | NCT00087438 | Lung Cancer | stereotactic bo... | 18 Years - | Radiation Therapy Oncology Group | |
| Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer | NCT00081302 | Lung Cancer | cetuximab carboplatin paclitaxel radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung Cancer | NCT00025571 | Lung Cancer | HPPH | 18 Years - | Roswell Park Cancer Institute | |
| Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib | NCT00570401 | Lung Cancer | dasatinib | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer | NCT00006458 | Lung Cancer | indium In 111 m... yttrium Y 90 mo... | 18 Years - | National Cancer Institute (NCI) | |
| Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers | NCT01344824 | Lung Cancer | bevacizumab carboplatin erlotinib hydro... pemetrexed diso... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | NCT00346320 | Lung Cancer | 3-dimensional c... | 18 Years - | Canadian Cancer Trials Group | |
| Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer | NCT00042835 | Adenocarcinoma ... Bronchoalveolar... Large Cell Lung... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | cisplatin etoposide erlotinib hydro... radiation thera... docetaxel paclitaxel carboplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung | NCT02466568 | Lung Cancer Adenocarcinoma ... | Nivolumab GM.CD40L Vaccin... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery | NCT00003387 | Lung Cancer | carboplatin chemotherapy paclitaxel radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed | NCT00003235 | Lung Cancer | carboplatin paclitaxel radiation thera... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00553462 | Lung Cancer | carboplatin erlotinib hydro... paclitaxel albu... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers | NCT01935336 | Adenocarcinoma ... Extensive Stage... Limited Stage S... Recurrent Non-s... Recurrent Small... Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-sm... | Ponatinib | 18 Years - | University of Colorado, Denver | |
| Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | NCT00005850 | Anxiety Disorde... Depression Fatigue Lung Cancer | cisplatin fluoxetine gemcitabine hyd... | - | Alliance for Clinical Trials in Oncology | |
| Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | NCT00234052 | Lung Cancer | bevacizumab carboplatin pemetrexed | 18 Years - 120 Years | Northwestern University | |
| Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery | NCT00003387 | Lung Cancer | carboplatin chemotherapy paclitaxel radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00085501 | Lung Cancer | cetuximab carboplatin paclitaxel | 18 Years - | SWOG Cancer Research Network | |
| Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00309998 | Lung Cancer | bevacizumab vinorelbine tar... | 70 Years - | University of Rochester | |
| Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer | NCT00028938 | Lung Cancer | epoetin alfa carboplatin paclitaxel radiation thera... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer | NCT01107626 | Lung Cancer | Paclitaxel Carboplatin Bevacizumab Pemetrexed Diso... | 18 Years - | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00006378 | Lung Cancer | carboplatin paclitaxel radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer | NCT00526461 | Lung Cancer | HPPH | 18 Years - 120 Years | Roswell Park Cancer Institute | |
| Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00077311 | Anemia Drug/Agent Toxi... Lung Cancer Neutropenia | darbepoetin alf... pegfilgrastim cisplatin docetaxel BNP7787 | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | NCT00004139 | Lung Cancer | docetaxel gemcitabine hyd... irinotecan hydr... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00085501 | Lung Cancer | cetuximab carboplatin paclitaxel | 18 Years - | SWOG Cancer Research Network | |
| Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | NCT00005850 | Anxiety Disorde... Depression Fatigue Lung Cancer | cisplatin fluoxetine gemcitabine hyd... | - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00005838 | Adenocarcinoma ... Adenosquamous C... Large Cell Lung... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | shark cartilage... placebo cisplatin vinorelbine tar... carboplatin paclitaxel radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers | NCT01935336 | Adenocarcinoma ... Extensive Stage... Limited Stage S... Recurrent Non-s... Recurrent Small... Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-sm... | Ponatinib | 18 Years - | University of Colorado, Denver | |
| Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | NCT00054392 | Lung Cancer | carboplatin gemcitabine hyd... paclitaxel | 18 Years - | Fox Chase Cancer Center | |
| RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma | NCT00101972 | Cancer | monoclonal anti... | 18 Years - | MacroGenics | |
| Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung | NCT01561456 | Non-small-cell ... Squamous Cell C... Adenocarcinoma ... | AXL1717 Docetaxel | 18 Years - | Axelar AB | |
| Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT00117962 | Lung Cancer | cetuximab carboplatin pemetrexed diso... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib | NCT00570401 | Lung Cancer | dasatinib | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer | NCT00004859 | Lung Cancer | carboplatin paclitaxel thalidomide radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer | NCT00077415 | Lung Cancer | gemcitabine hyd... triapine | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | NCT00776100 | Lung Cancer | clinical observ... radiation thera... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer | NCT00616499 | Lung Cancer | gefitinib neoadjuvant the... therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer | NCT00003117 | Lung Cancer | carboplatin paclitaxel | 18 Years - | Alliance for Clinical Trials in Oncology |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
